Middle East Cystic Fibrosis Associa (EIN 851096028) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2020

Legal Domicile

Phone

3393688026

Tax Period

2024-01-01 to 2024-12-31

Middle East Cystic Fibrosis Associa, founded in 2020, is a small nonprofit in the Diseases & Disorders sector that reported $201K in total revenue in fiscal year 2024. Revenue fell 34% from the prior year — a significant decline worth monitoring. The organization ran a surplus of $38K, a strong 19% operating margin.

Mission

The mission of the organization is to improve the health outcomes of cystic fibrosis patients in the Middle East through early diagnosis, quality care, medications, and equipment that extends the life expectancy.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $141,903

Program Service Revenue $59,420

Investment Income $10

Other Revenue $0

TOTAL REVENUE $201,333

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $151,286

Other Expenses $163,414

TOTAL EXPENSES $163,414

Year-over-Year Comparison

	2024	2023	Change
Revenue	$201,333	$304,810	-0.3%
Expenses	$163,414	$310,088	-0.5%
Net Income	$37,919	$-5,278	-8.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$69,200

Total Directors

$69,200

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Christine Marie Noke	President Executive Director	40.00	Officer Director	$69,200	$0	$69,200
Jill Weinstien	Treasurer Secretary	2.00	Officer Director	$0	$0	$0
Bulent Karadag	Director	5.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$201,333	$163,414	$75,382	$37,919
2023	$304,816	$310,088	$43,463	$-5,272
2020	$427,227	$357,148	$169,095	$70,079

Middle East Cystic Fibrosis Associa